Quide vs. Mellaril in chronic schizophrenic patients.
作者信息
Gallant D M, Bishop M P
出版信息
Curr Ther Res Clin Exp. 1972 Jan;14(1):10-6.
PMID:4621558
Abstract
摘要
相似文献
1
Quide vs. Mellaril in chronic schizophrenic patients.
Curr Ther Res Clin Exp. 1972 Jan;14(1):10-6.
2
Butaperazine in chronic schizophrenic patients: a doubled-blinf study.慢性精神分裂症患者使用丁酰拉嗪：一项双盲研究。
Curr Ther Res Clin Exp. 1969 Jan;11(1):5-8.
3
Clinical studies with propericiazine (R.P. 8909).
Dis Nerv Syst. 1967 Aug;28(8):526-31.
4
The treatment of lobotomized schizophrenic patients with butaperazine.
Curr Ther Res Clin Exp. 1969 Jul;11(7):418-28.
5
Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Curr Ther Res Clin Exp. 1972 Jul;14(7):376-80.
6
Evaluation of a new antipsychotic agent. Piperacetazine (quide).一种新型抗精神病药物的评估。哌西他嗪（奎地）。
JAMA. 1971 Feb 1;215(5):783-4. doi: 10.1001/jama.1971.03180180059011.
7
Piperacetazine in chronic mental patients: clinical observations and new urine color test.哌普嗪在慢性精神病患者中的应用：临床观察及新的尿液颜色试验
Curr Ther Res Clin Exp. 1972 Nov;14(11):689-95.
8
A clinical study with propericiazine in chronic psychotic patients.
Curr Ther Res Clin Exp. 1971 Jun;13(6):353-8.
9
Drug responses of three hospital population samples participating in a collaborative study.
Arzneimittelforschung. 1966 Feb;16(2):290-3.
10
Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
Dis Nerv Syst. 1968 Jul;29(7):478-84.
引用本文的文献
1
Thioridazine for schizophrenia.用于治疗精神分裂症的硫利达嗪。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2.
Zotero 插件